Krieger, Theresia
Jozwiak, Leonie
Ebersbach, Georg
Suess, Thorsten
Falkenburger, Björn
Feige, Tim
Eggers, Carsten
Warnecke, Tobias
Scholl, Winfried
Schmidt-Heisch, Christian
Folkerts, Ann-Kristin
Kalbe, Elke
Seven, Ümran Sema
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 9 February 2024
Accepted: 29 May 2024
First Online: 18 June 2024
Declarations
:
: This study was approved by the Ethics Committee of the Faculty of Medical at the University of Cologne (No. 22-1346) and adhered to the principles of the Declaration of Helsinki and relevant national and European data protection regulations. Before data collection, the researchers provided written and oral information to each participant, explaining the study’s procedures and objectives. Written informed consent was then obtained from each participant. Each participant was offered €30 compensation to acknowledge their participation.
: Not applicable.
: The authors TK, LJ, GE, TS, NF, TF, CE, TW, WS, CSH and ÜSS declare they have no competing interests.EK has received grants from the German Ministry of Education and Research, the German General Joint Committee, the German Parkinson Society, and STADAPHARM GmbH (Berlin, Germany) as well as honoraria from AbbVie GmbH (Ludwigshafen, Germany) and memodio GmbH (Potsdam, Germany) and license fees from Prolog GmbH (Landau, Germany). EK is one of the authors of the cognitive intervention series “NEUROvitalis” but receives no corresponding honoraria.AKF has received grants from the German Parkinson Society, the German Alzheimer’s Society, the German Parkinson Foundation, STADAPHARM GmbH and the German General Joint Committee, as well as honoraria from Springer Medizin Verlag GmbH (Heidelberg, Germany), Springer-Verlag GmbH (Berlin, Germany), ProLog Wissen GmbH (Cologne, Germany), Seminar- und Fortbildungszentrum (Rheine, Germany), LOGOMANIA, Fendt & Sax GbR (Munich, Germany), LOGUAN (Ulm, Germany), dbs e.V. (Moers, Germany), STADAPHARM GmbH (Bad Vilbel, Germany), NEUROPSY (St. Konrad, Austria), Multiple Sclerosis Society Vienna (Vienna, Austria), and Gossweiler Foundation (Bern, Switzerland). AKF is one of the authors of the cognitive intervention series ‘NEUROvitalis’ but receives no corresponding honoraria.